Cargando…
Lymphocyte cytosolic protein 2 is a novel prognostic marker in lung adenocarcinoma
OBJECTIVE: Lymphocyte cytosolic protein 2 (LCP2) is often ectopically expressed in various human tumors. However, the clinical significance and role of LCP2 in lung adenocarcinoma (LUAD) remain unclear. This study explored the prognostic significance of LCP2 in LUAD patients. METHODS: LCP2 expressio...
Autores principales: | Huo, Yishan, Zhang, Kainan, Han, Songtao, Feng, Yangchun, Bao, Yongxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649447/ https://www.ncbi.nlm.nih.gov/pubmed/34816740 http://dx.doi.org/10.1177/03000605211059681 |
Ejemplares similares
-
Knowledge database assisted gene marker selection for chronic lymphocytic leukemia
por: Xiang, Xixi, et al.
Publicado: (2018) -
Heparin coated meta-organic framework co-delivering doxorubicin and quercetin for effective chemotherapy of lung carcinoma
por: Sun, Xiaojun, et al.
Publicado: (2020) -
Identification of differentially expressed genes between mucinous
adenocarcinoma and other adenocarcinoma of colorectal cancer using
bioinformatics analysis
por: Zhang, Xue, et al.
Publicado: (2020) -
Evaluation of endothelial microparticles as a prognostic marker in hemolytic disease of the newborn in China
por: Zhu, Xiao-jing, et al.
Publicado: (2019) -
CDK1 serves as a potential prognostic biomarker and target for lung cancer
por: Li, Mingyao, et al.
Publicado: (2020)